Drug Profile
Research programme: G-protein coupled receptor 40 agonists - Connexios
Alternative Names: CNX-011; CNX-011-67Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Connexios Life Sciences
- Class Small molecules
- Mechanism of Action G protein-coupled receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in India
- 15 Oct 2015 Preclinical development is ongoing (Connexios' pipeline, October 2015)
- 09 May 2014 Connexios is open to partnering and licensing opportunities to advance the development of this programme, as of 09 May 2014. http://connexios.com/